EMR Combined with CRB-65 Superior to CURB-65 in Predicting Mortality in Patients with Community-Acquired Pneumonia

被引:1
|
作者
Sun, Yi [1 ,2 ]
Wang, Hong [3 ]
Gu, Minghao [4 ]
Zhang, Xingyu [5 ]
Han, Xiudi [1 ]
Liu, Xuedong [1 ]
机构
[1] Qingdao Municipal Hosp Grp, Dept Resp & Crit Care Med, Qingdao 266000, Shandong, Peoples R China
[2] Shandong Second Med Univ, Sch Clin Med, Weifang 261000, Shandong, Peoples R China
[3] Hosp Acquired Infect Control Dept, Qingdao Municipal Hosp Grp, Qingdao 266000, Shandong, Peoples R China
[4] Qingdao Univ, Sch Med, Qingdao 266000, Shandong, Peoples R China
[5] Qingdao Municipal Hosp Grp, Human Resources Dept, Qingdao 266000, Shandong, Peoples R China
来源
INFECTION AND DRUG RESISTANCE | 2024年 / 17卷
关键词
community-acquired pneumonia; EMR; ELR; CURB-65; CRB-65; severity of disease; mortality; INFECTIOUS-DISEASES-SOCIETY; TO-MONOCYTE RATIO; THORACIC-SOCIETY; SEVERITY; ADULTS;
D O I
10.2147/IDR.S443045
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Data about eosinophil-to-lymphocyte ratio (ELR) and eosinophil-to-monocyte ratio (EMR) in patients with communityacquired pneumonia (CAP) are rare. We aimed to evaluate the role of EMR and ELR in predicting disease severity and mortality in patients with CAP. Methods: A total of 454 patients (76 with severe CAP (SCAP), 378 with non-SCAP) were enrolled from November 18, 2020, and November 21, 2021. Laboratory examination on day 1 after admission was measured. The ELR and EMR values were calculated for patients. Propensity score matching (PSM) was performed to balance potential confounding factors. Binary logistic regression model was fitted to identify the potential risk factors for disease severity and Cox proportional hazards regression model analysis for mortality in CAP. Receiver operating characteristic (ROC) analysis was performed to distinguish disease severity and mortality. Results: EMR and ELR at admission were significantly lower in SCAP patients than in non-SCAP patients (P<0.001). EMR < 0.018 ([OR] = 12.104, 95% CI: 4.970-29.479), neutrophil (NEU) ([OR]=1.098, 95% CI:1.005-1.199), and age ([OR]=1.091, 95% CI:1.054- 1.130) were independent risk factors for disease severity of CAP. EMR < 0.032 ([HR] = 5.816, 95% CI: 1.704-9.848) was an independent predictor of in-hospital mortality. Combining EMR or ELR with CRB-65 improved the overall accuracy of disease severity prediction (AUC from 0.894 to 0.937), the same as CURB-65. The area under the curve of EMR (AUC=0.704; 95% CI: 0.582-0.827) to predict in-hospital mortality was higher than that of CURB-65 (AUC=0.619; 95% CI: 0.484-0.754). Otherwise, EMR combined with CRB-65 (AUC=0.721; 95% CI: 0.592-0.851) had significantly higher diagnostic accuracy for in-hospital mortality than that of CURB-65 alone. Conclusion: EMR combined with CRB-65 was superior to CURB-65 in predicting mortality in patients with CAP. This new combination was simpler and easier to obtain for physicians in clinics or admission, and it was more convenient for early recognition of patients with poor prognoses.
引用
收藏
页码:463 / 473
页数:11
相关论文
共 50 条
  • [21] Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia
    Falcone, Marco
    Corrao, Salvatore
    Venditti, Mario
    Serra, Pietro
    Licata, Giuseppe
    INTERNAL AND EMERGENCY MEDICINE, 2011, 6 (05) : 431 - 436
  • [22] Comparison of severity scoring systems A-DROP and CURB-65 for community-acquired pneumonia
    Shindo, Yuichiro
    Sato, Shinji
    Maruyama, Eiichi
    Ohashi, Takamasa
    Ogawa, Masahiro
    Imaizumi, Kazuyoshi
    Hasegawa, Yoshinori
    RESPIROLOGY, 2008, 13 (05) : 731 - 735
  • [23] Expanded CURB-65: a new score system predicts severity of community-acquired pneumonia with superior efficiency
    Liu, Jin-liang
    Xu, Feng
    Zhou, Hui
    Wu, Xue-jie
    Shi, Ling-xian
    Lu, Rui-qing
    Farcomeni, Alessio
    Venditti, Mario
    Zhao, Ying-li
    Luo, Shu-ya
    Dong, Xiao-jun
    Falcone, Marco
    SCIENTIFIC REPORTS, 2016, 6
  • [24] A new scoring system to predict mortality in community-acquired pneumonia: CURB (S)-65
    Bahcecioglu, S. N.
    Kokturk, N.
    Baha, A.
    Yapar, D.
    Aksakal, F. N. B.
    Gunduz, C.
    Tasbakan, S.
    Sayiner, A.
    Coskun, A. S.
    Yaman, F.
    Cilli, A.
    Celenk, B.
    Kilinc, O.
    Mersin, S. S.
    Hazar, A.
    Tokgoz, F.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (13) : 6293 - 6300
  • [25] Assessment of oxygenation and comorbidities improves outcome prediction in patients with community-acquired pneumonia with a low CRB-65 score
    Kolditz, M.
    Ewig, S.
    Schuette, H.
    Suttorp, N.
    Welte, T.
    Rohde, G.
    JOURNAL OF INTERNAL MEDICINE, 2015, 278 (02) : 193 - 202
  • [26] Performance of PSI, CURB-65, and SCAP scores in predicting the outcome of patients with community-acquired and healthcare-associated pneumonia
    Marco Falcone
    Salvatore Corrao
    Mario Venditti
    Pietro Serra
    Giuseppe Licata
    Internal and Emergency Medicine, 2011, 6 : 431 - 436
  • [27] Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes
    Krueger, S.
    Ewig, S.
    Marre, R.
    Papassotiriou, J.
    Richter, K.
    von Baum, H.
    Suttorp, N.
    Welte, T.
    EUROPEAN RESPIRATORY JOURNAL, 2008, 31 (02) : 349 - 355
  • [28] Validation of the qSOFA and CRB-65 in SARS-CoV-2-infected community-acquired pneumonia
    Richter, Tina
    Tesch, Falko
    Schmitt, Jochen
    Koschel, Dirk
    Kolditz, Martin
    ERJ OPEN RESEARCH, 2023, 9 (03)
  • [29] CURB-65 and other markers of illness severity in community-acquired pneumonia among HIV-positive patients
    Almeida, Andre
    Almeida, Ana Rita
    Branco, Sara Castelo
    Vesza, Zsofia
    Pereira, Rui
    INTERNATIONAL JOURNAL OF STD & AIDS, 2016, 27 (11) : 998 - 1004
  • [30] Association of serum procalcitonin and C-reactive protein levels with CURB-65 criteria among patients with community-acquired pneumonia
    Keramat, Fariba
    Basir, Hamid Reza Ghasemi
    Abdoli, Elham
    Aghdam, Arghavan Shafiei
    Poorolajal, Jalal
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2018, 11 : 217 - 223